321 related articles for article (PubMed ID: 28108732)
21. Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition.
Ruan JS; Liu YP; Zhang L; Yan LG; Fan FT; Shen CS; Wang AY; Zheng SZ; Wang SM; Lu Y
Acta Pharmacol Sin; 2012 Oct; 33(10):1325-31. PubMed ID: 22983392
[TBL] [Abstract][Full Text] [Related]
22. Regulation of glycogen synthase kinase-3 by thymosin beta-4 is associated with gastric cancer cell migration.
Ryu YK; Lee YS; Lee GH; Song KS; Kim YS; Moon EY
Int J Cancer; 2012 Nov; 131(9):2067-77. PubMed ID: 22328534
[TBL] [Abstract][Full Text] [Related]
23. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
[TBL] [Abstract][Full Text] [Related]
24. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma.
Liu S; Kumar SM; Lu H; Liu A; Yang R; Pushparajan A; Guo W; Xu X
J Pathol; 2012 Jan; 226(1):61-72. PubMed ID: 22131135
[TBL] [Abstract][Full Text] [Related]
26. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
[TBL] [Abstract][Full Text] [Related]
27. Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE.
Lai SS; Xue B; Yang Y; Zhao L; Chu CS; Hao JY; Wen CJ
Cancer Genet; 2012 Nov; 205(11):552-62. PubMed ID: 23142633
[TBL] [Abstract][Full Text] [Related]
28. Nobiletin Inhibits Angiogenesis by Regulating Src/FAK/STAT3-Mediated Signaling through PXN in ER⁺ Breast Cancer Cells.
Sp N; Kang DY; Joung YH; Park JH; Kim WS; Lee HK; Song KD; Park YM; Yang YM
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468300
[TBL] [Abstract][Full Text] [Related]
29. Requirement of PEA3 for transcriptional activation of FAK gene in tumor metastasis.
Li S; Huang X; Zhang D; Huang Q; Pei G; Wang L; Jiang W; Hu Q; Tan R; Hua ZC
PLoS One; 2013; 8(11):e79336. PubMed ID: 24260201
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression.
Wu DG; Wang YY; Fan LG; Luo H; Han B; Sun LH; Wang XF; Zhang JX; Cao L; Wang XR; You YP; Liu N
Chin Med J (Engl); 2011 Sep; 124(17):2616-21. PubMed ID: 22040413
[TBL] [Abstract][Full Text] [Related]
31. Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.
Bao X; Ren T; Huang Y; Wang S; Zhang F; Liu K; Zheng B; Guo W
J Exp Clin Cancer Res; 2016 Aug; 35(1):129. PubMed ID: 27576314
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.
Cao HH; Chu JH; Kwan HY; Su T; Yu H; Cheng CY; Fu XQ; Guo H; Li T; Tse AK; Chou GX; Mo HB; Yu ZL
Sci Rep; 2016 Feb; 6():21731. PubMed ID: 26911838
[TBL] [Abstract][Full Text] [Related]
33. ZIC5 Drives Melanoma Aggressiveness by PDGFD-Mediated Activation of FAK and STAT3.
Satow R; Nakamura T; Kato C; Endo M; Tamura M; Batori R; Tomura S; Murayama Y; Fukami K
Cancer Res; 2017 Jan; 77(2):366-377. PubMed ID: 27671679
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin.
Liu YX; Xu BW; Niu XD; Chen YJ; Fu XQ; Wang XQ; Yin CL; Chou JY; Li JK; Wu JY; Bai JX; Wu Y; Li SM; Yu ZL
Pharmacol Res; 2022 Jan; 175():105983. PubMed ID: 34822972
[TBL] [Abstract][Full Text] [Related]
35. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression.
Bing L; Hong C; Li-Xin S; Wei G
Arch Gynecol Obstet; 2014 Sep; 290(3):533-41. PubMed ID: 24699721
[TBL] [Abstract][Full Text] [Related]
37. c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.
Nihal M; Wood GS
Oncotarget; 2016 Aug; 7(33):53869-53880. PubMed ID: 27472394
[TBL] [Abstract][Full Text] [Related]
38. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
Liu LH; Li H; Li JP; Zhong H; Zhang HC; Chen J; Xiao T
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):31-8. PubMed ID: 22093834
[TBL] [Abstract][Full Text] [Related]
39. Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.
Liu J; Qu X; Shao L; Hu Y; Yu X; Lan P; Guo Q; Han Q; Zhang J; Zhang C
Cancer Biol Ther; 2018 Mar; 19(3):160-168. PubMed ID: 29370558
[TBL] [Abstract][Full Text] [Related]
40. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
